Document Detail


Circulating adipocyte fatty acid binding protein levels in healthy preterm infants: Positive correlation with weight gain and total-cholesterol levels.
MedLine Citation:
PMID:  20231079     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Adipocyte fatty acid binding protein (a-FABP) has been suggested to play an important role in the pathogenesis of metabolic syndrome. Preterm infants are at risk for the later development of insulin resistance, and, possibly, other components of metabolic syndrome. AIM: To determine circulating levels of a-FABP in preterm infants and examine possible associations of a-FABP with metabolic indices (serum lipids, glucose, and insulin levels, and homeostasis model assessment index of insulin resistance [HOMA-IR]), levels of leptin and adiponectin, anthropometric parameters and weight gain. STUDY DESIGN: Prospective cohort study. SUBJECTS: 55 healthy preterm (mean [SD] gestational age 32.8 [1.8] weeks) and 23 fullterm infants (reference group). OUTCOME MEASURES: Serum a-FABP, lipids, glucose, insulin, leptin and adiponectin levels at 31.9 [10.4] days of life. RESULTS: Serum a-FABP levels did not differ significantly between preterm and fullterm infants. A-FABP levels correlated positively with total-cholesterol [total-C] in both preterm and fullterm infants (beta=0.33; p=0.01 and beta=0.33; p=0.04, respectively). In addition to total-C, weight gain correlated independently with a-FABP levels in preterm infants (beta=0.36, p=0.01). CONCLUSIONS: An association between a-FABP levels and indices of insulin resistance was not present in infants studied. As the development of insulin resistance in children born prematurely is possibly associated with weight gain in early postnatal life, follow-up of our study population is necessary to demonstrate whether a-FABP levels, shown to correlate with weight gain in preterm infants, are a predictive marker for the later development of insulin resistance in these infants.
Authors:
Tania Siahanidou; Alexandra Margeli; Maria Davradou; Filia Apostolakou; Ioannis Papassotiriou; Eleftheria Roma; Helen Mandyla; George Chrousos
Related Documents :
22942619 - Louisa's birth.
9360769 - The effect of prenatal photoperiodic history on the postnatal endocrine status of femal...
17566429 - Lefties are still a little shorter.
11061779 - Daily physical activity program increases bone mineralization and growth in preterm ver...
2843619 - Sodium deficit causing decreased weight gain and metabolic acidosis in infants with ile...
17167949 - Bacillus calmette-guerin vaccination in preterm infants.
10437939 - The reference range of cd4+ and cd8+ t-lymphocytes in healthy non-infected infants born...
9219459 - Cell division in placentas of appropriate and small-for-gestational-age infants. a flow...
21377819 - Coxsackie b3 myocarditis in a case of sudden unexpected death in young athlete: histopa...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-03-15
Journal Detail:
Title:  Early human development     Volume:  86     ISSN:  1872-6232     ISO Abbreviation:  Early Hum. Dev.     Publication Date:  2010 Apr 
Date Detail:
Created Date:  2010-05-31     Completed Date:  2010-09-02     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7708381     Medline TA:  Early Hum Dev     Country:  Ireland    
Other Details:
Languages:  eng     Pagination:  197-201     Citation Subset:  IM    
Copyright Information:
2010 Elsevier Ireland Ltd. All rights reserved.
Affiliation:
First Department of Pediatrics, Athens University Medical School, Greece. siahan@med.uoa.gr <siahan@med.uoa.gr>
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adiponectin / blood
Blood Glucose / analysis
Cholesterol / blood*
Fatty Acid-Binding Proteins / blood*
Female
Homeostasis
Humans
Immunoenzyme Techniques
Infant, Newborn
Infant, Premature*
Insulin / blood
Insulin Resistance
Leptin / blood
Male
Prospective Studies
Weight Gain*
Chemical
Reg. No./Substance:
0/Adiponectin; 0/Blood Glucose; 0/FABP4 protein, human; 0/Fatty Acid-Binding Proteins; 0/Leptin; 11061-68-0/Insulin; 57-88-5/Cholesterol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Initial results of a Phase I dose-escalation trial of concurrent and maintenance erlotinib and reirr...
Next Document:  A comparison between the pregnancy outcome in women both with or without threatened abortion.